Tracizoline | CAS#65248-90-0 | I2-imidazoline receptor agonist

MedKoo Cat#: 463803 | Name: Tracizoline

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Tracizoline is a potent I2-imidazoline receptor agonist.

Chemical Structure

Tracizoline

CAS#65248-90-0

Theoretical Analysis

MedKoo Cat#: 463803

Name: Tracizoline

CAS#: 65248-90-0

Chemical Formula: C11H12N2

Exact Mass: 172.1000

Molecular Weight: 172.23

Elemental Analysis: C, 76.71; H, 7.02; N, 16.27

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Tracizoline; 2-Styryl-imidazolin;

IUPAC/Chemical Name

(E)-2-styryl-4,5-dihydro-1H-imidazole

InChi Key

IGISUADTPSLENQ-VOTSOKGWSA-N

InChi Code

InChI=1S/C11H12N2/c1-2-4-10(5-3-1)6-7-11-12-8-9-13-11/h1-7H,8-9H2,(H,12,13)/b7-6+

SMILES Code

C1(/C=C/C2=CC=CC=C2)=NCCN1

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 172.23 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Hernández-Hernández E, García-Fuster MJ. Evaluating the effects of 2-BFI and tracizoline, two potent I2-imidazoline receptor agonists, on cognitive performance and affect in middle-aged rats. Naunyn Schmiedebergs Arch Pharmacol. 2021 Jan 7. doi: 10.1007/s00210-020-02042-6. Epub ahead of print. PMID: 33415506. 2: Siemian JN, Qiu Y, Zhang Y, Li JX. Role of intracellular Ca2+ signaling in the antinociceptive and discriminative stimulus effects of the imidazoline I2 receptor agonist 2-BFI in rats. Psychopharmacology (Berl). 2017 Nov;234(22):3299-3307. doi: 10.1007/s00213-017-4719-1. Epub 2017 Aug 19. PMID: 28825118; PMCID: PMC5660937. 3: Qiu Y, Zhang Y, Li JX. Discriminative stimulus effects of the imidazoline I2 receptor ligands BU224 and phenyzoline in rats. Eur J Pharmacol. 2015 Feb 15;749:133-41. doi: 10.1016/j.ejphar.2015.01.013. Epub 2015 Jan 21. PMID: 25617792; PMCID: PMC4331254. 4: Qiu Y, He XH, Zhang Y, Li JX. Discriminative stimulus effects of the novel imidazoline I₂ receptor ligand CR4056 in rats. Sci Rep. 2014 Oct 13;4:6605. doi: 10.1038/srep06605. PMID: 25308382; PMCID: PMC4194429. 5: Li JX, Thorn DA, Qiu Y, Peng BW, Zhang Y. Antihyperalgesic effects of imidazoline I(2) receptor ligands in rat models of inflammatory and neuropathic pain. Br J Pharmacol. 2014 Mar;171(6):1580-90. doi: 10.1111/bph.12555. PMID: 24329196; PMCID: PMC3954494. 6: Thorn DA, An XF, Zhang Y, Pigini M, Li JX. Characterization of the hypothermic effects of imidazoline I₂ receptor agonists in rats. Br J Pharmacol. 2012 Jul;166(6):1936-45. doi: 10.1111/j.1476-5381.2012.01894.x. PMID: 22324428; PMCID: PMC3402816. 7: Treder AP, Andruszkiewicz R, Zgoda W, Walkowiak A, Ford C, Hudson AL. New imidazoline/α(2)-adrenoceptors affecting compounds-4(5)-(2-aminoethyl)imidazoline (dihydrohistamine) derivatives. Synthesis and receptor affinity studies. Bioorg Med Chem. 2011 Jan 1;19(1):156-67. doi: 10.1016/j.bmc.2010.11.039. Epub 2010 Nov 25. PMID: 21159515. 8: Gentili F, Cardinaletti C, Carrieri A, Ghelfi F, Mattioli L, Perfumi M, Vesprini C, Pigini M. Involvement of I2-imidazoline binding sites in positive and negative morphine analgesia modulatory effects. Eur J Pharmacol. 2006 Dec 28;553(1-3):73-81. doi: 10.1016/j.ejphar.2006.09.031. Epub 2006 Sep 26. PMID: 17081513. 9: Polidori C, Gentili F, Pigini M, Quaglia W, Panocka I, Massi M. Hyperphagic effect of novel compounds with high affinity for imidazoline I(2) binding sites. Eur J Pharmacol. 2000 Mar 24;392(1-2):41-9. doi: 10.1016/s0014-2999(00)00014-5. PMID: 10748271. 10: Pigini M, Bousquet P, Brasili L, Carrieri A, Dontenwill M, Gentili F, Giannella M, Leonetti F, Piergentili A, Quaglia W, Carotti A. Binding of tracizolines to the imidazoline receptor. Role of lipophilicity in quantitative structure-activity relationship models. Ann N Y Acad Sci. 1999 Jun 21;881:118-22. doi: 10.1111/j.1749-6632.1999.tb09351.x. PMID: 10415907. 11: Pigini M, Bousquet P, Brasili L, Carrieri A, Cavagna R, Dontenwill M, Gentili F, Giannella M, Leonetti F, Piergentili A, Quaglia W, Carotti A. Ligand binding to I2 imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models. Bioorg Med Chem. 1998 Dec;6(12):2245-60. doi: 10.1016/s0968-0896(98)80005-9. PMID: 9925287. 12: Pigini M, Bousquet P, Carotti A, Dontenwill M, Giannella M, Moriconi R, Piergentili A, Quaglia W, Tayebati SK, Brasili L. Imidazoline receptors: qualitative structure-activity relationships and discovery of tracizoline and benazoline. Two ligands with high affinity and unprecedented selectivity. Bioorg Med Chem. 1997 May;5(5):833-41. doi: 10.1016/s0968-0896(97)00009-6. PMID: 9208095.